Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 antibody test
Clinical narrative: Reoccurrence of covid symptoms and positive test on the 9th day after positive test.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Reoccurrence of covid symptoms and positive test on the 9th day after positive test.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: COVID-19 Vaccine. Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2022, the patient experienced COVID-19 (Reoccurrence of covid symptoms and positive test on the 9th day after positive test.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 05-May-2022 to 10-May-2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (Reoccurrence of covid symptoms and positive test on the 9th day after positive test.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2022, SARS-CoV-2 antibody test: positive (Positive) Positive. On 10-May-2022, SARS-CoV-2 antibody test: negative (Negative) Negative. On 14-May-2022, SARS-CoV-2 antibody test: positive (Positive) Positive.         No concomitant medication information was provided. On the first day of positive test, patient was prescribed with Paxlovid and symptoms were stopped. Patient then tested negative after day 5.  Patient was treated with antibiotic and steroid. It was reported that patient was not taking any other medications or products within 2 weeks of starting COVID-19 treatment.  Company Comment: This spontaneous case reported by consumer concerns a patient of unknown age and gender, with relevant history of a previously administered unspecified Covid19 vaccine, who experienced unexpected, non-serious AESI Covid19 approximately 5 months after receiving mRNA-1273 (reported as third dose).  Patient had unspecified Covid symptoms and tested positive for Covid19.   The patient was given Paxlovid and symptoms resolved; on the 5th day the patient tested negative for Covid19.  However, on the ninth day there was recurrence of unspecified symptoms and the patient tested positive for Covid19 again.  Patient was treated with unspecified antibiotics and steroids.  The reported outcome was not recovered.  The benefit risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case reported by consumer concerns a patient of unknown age and gender, with relevant history of a previously administered unspecified Covid19 vaccine, who experienced unexpected, non-serious AESI Covid19 approximately 5 months after receiving mRNA-1273 (reported as third dose).  Patient had unspecified Covid symptoms and tested positive for Covid19.   The patient was given Paxlovid and symptoms resolved; on the 5th day the patient tested negative for Covid19.  However, on the ninth day there was recurrence of unspecified symptoms and the patient tested positive for Covid19 again.  Patient was treated with unspecified antibiotics and steroids.  The reported outcome was not recovered.  The benefit risk relationship of mRNA-1273 is not affected by this report.